Original Query: ALL
Previous Study | Return to List | Next Study

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00895739
Recruitment Status : Unknown
Verified May 2009 by National Cancer Institute (NCI).
Recruitment status was:  Recruiting
First Posted : May 8, 2009
Last Update Posted : August 12, 2013
Information provided by:
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Study Completion Date : No date given